For instance, the presence of a genetic variation in the non-coding sequence of ERBB2 generating a binding motif for the major inducer of epithelial-to-mesenchymal transition ZEB1 can potentially increase the aggressiveness and tumourigenic potential of HER2-positive breast cancer cells. This evidence concerns the gene ZEB1 and breast cancer.